ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AHG vs QNST // EV/EBITDA & P/E VALUATION

Akso Health Group ADS (NASDAQ) VS. QuinStreet Inc. (NASDAQ) • 15-METRIC TALLY: AHG 1 — QNST 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHG VS. QNST) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AHG QNST SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -0.10% 10.10% -10.20 QNST /gross-margins <GO>
Return on Invested Capital (ROIC) — 2.60% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 109.9x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 8.45% -9.57 QNST /fcf-yield <GO>
Operating Margin -60.00% 0.60% -60.60 QNST /operating-margins <GO>
Net Profit Margin -60.00% 0.40% -60.40 QNST /net-margins <GO>
Revenue Growth (YoY) -6.40% 78.30% -84.70 QNST /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.24 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 QNST /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.8 61.3 -7.57 QNST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.14B $980.8M $158.6M AHG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AHG REV QNST REV AHG GROSS % QNST GROSS % AHG FCF QNST FCF
FY 2025 $13.8M $1.09B -0.1% 10.1% -$12.8M $82.9M
FY 2024 $14.8M $613.5M -1.9% 7.5% $1.0M $6.7M
FY 2023 $2.4M $580.6M — — $1.4M $11.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHG // BETA —
QNST // BETA —